Decoy Therapeutics Files Prospectus Related To The Resale Of Up To 2,368,868 Common Shares
-SEC Filing
Stocks · News reference
U.S. CDC Says As Of August 6, 2,465 Confirmed Measles Cases Were Reported In U.S. In 2026; There Have Been 38 New Measles Outbreaks Reported In 2026, And 94% Of Confirmed Cases Are Outbreak-Associated
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Decoy Therapeutics Says Preclinical Data Show Single Intranasal Dose Of DCOY-CoV Maintains Drug Levels For Up To 7 Days; Expects Clinical Trials In 2027
Emergent BioSolutions shares are trading lower. The company announced its CFO Richard Lindahl will retire, with Treasurer Frank Vargo set to serve as interim CFO effective January 1, 2027.
Emergent Biosolutions Appoints Treasurer Frank Vargo As Interim CFO, Effective Jan. 1, 2027, Succeeding Richard Lindahl
https://www.sec.gov/ix?doc=/Archives/edgar/data/1367644/000136764426000098/ebs-20261016.htm
8-K filing — Emergent BioSolutions Inc. (EBS)
Filed: 2026-10-16 AccNo: 0001367644-26-000098 Size: 213 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
'Russia Denies Report of Second Case of Illness in Siberia' - Bloomberg
https://www.bloomberg.com/news/articles/2026-10-08/russia-denies-report-of-second-case-of-illness-in-siberia